Table 1 Correlations between SETD5 expression and clinicopathological features in non-small cell lung cancer (NSCLC)
| Clinical parameters | Number (N = 147) | SETD5 expression | χ2 | P | |
|---|---|---|---|---|---|
| Positive | Negative | ||||
| Age (years) | 0.573 | 0.449 | |||
| < 59 | 65 | 35 | 30 | ||
| ≥ 59 | 82 | 39 | 43 | ||
| Gender | 1.551 | 0.213 | |||
| Male | 88 | 48 | 40 | ||
| Female | 59 | 26 | 33 | ||
| Histological type | 0.993 | 0.609 | |||
| Squamous cell carcinoma | 54 | 27 | 27 | ||
| Adenocarcinoma | 92 | 46 | 46 | ||
| Large cell carcinoma | 1 | 1 | 0 | ||
| Differentiation | 0.329 | 0.566 | |||
| Well | 57 | 27 | 30 | ||
| Moderate + Poor | 90 | 47 | 43 | ||
| TNM stages | 12.590 | < 0.001 | |||
| I + II | 103 | 42 | 61 | ||
| III | 44 | 32 | 12 | ||
| Lymph node metastasis | 15.252 | < 0.001 | |||
| Positive | 66 | 45 | 21 | ||
| Negative | 81 | 29 | 52 | ||